Mylan

991 articles about Mylan

• Mylan Inc. Announces Change in Board Leadership

  5/7/2009

• Mylan Inc.'s Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments

  4/20/2009

• Mylan Inc. Declares Quarterly Preferred Stock Dividend

  4/16/2009

• Mylan Inc. Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment

  4/14/2009

• Andrew G. Cuneo Joins Mylan Inc. as Vice President of Global Business Development

  4/13/2009

• Mylan Inc. and Schering-Plough Corporation Settle Clarinex Patent Lawsuit

  4/8/2009

• Mylan Inc. Execs Get 41% Raise; CEO Takes Company Jet on Vacation for "Security" Reasons

  4/1/2009

• Mylan Inc. to Pay $133 Million for Rest of Matrix Laboratories Limited

  3/27/2009

• Shire plc Extends Fosrenol Lawsuit to Mylan Inc.

  3/20/2009

• Mylan Inc.'s Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

  3/12/2009

• Mylan Inc.'s Matrix Laboratories Limited Receives World Health Organization Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor

  2/25/2009

• Mylan Inc. Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008

  2/20/2009

• Mylan Inc. Announces Transition of Chief Financial Officer

  2/20/2009

• Mylan Inc. Vice Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell

  2/19/2009

• Mylan Inc. Vice Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Opening Bell

  2/19/2009

• Barr Laboratories, Mylan Inc. Plan Generics of Shire plc's Fosrenol Drug

  2/9/2009

• Mylan Inc. Receives FDA Approval for First-to-File Generic Depakote(R) ER

  1/30/2009

• Mylan Inc. Declares Quarterly Preferred Stock Dividend

  1/30/2009

• Mylan Inc. Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD

  1/28/2009

• FDA Approves Mylan Inc.'s Generic Version of Prilosec

  1/23/2009